![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.378, 2002-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab prolongs survival in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab plus docetaxel in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab: In HER2 and Hormone Receptor Co-Positive Metastatic Breast Cancer
By Orman Jennifer S. Perry Caroline M.
Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Schilling G. Bruweleit M. Harbeck N. Thomssen C. Becker K. Hoffmann R. Villena C. Schütte M. Hossfeld D. Bokemeyer C. Wit M.
Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. :